| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| CYP2C9 |
1-Methyl-6-pyridin-3-yl-3,4-dihydroquinolin-2(1H)-one |
NA |
125000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| CYP2C9 |
1-(1-(2-(pyrrolidin-1-yl)ethyl)-1H-indazol-5-yl)-4-(4-(trifluoromethyl)phenyl)pyridin-2(1H)-one |
NA |
10000000 |
NA |
NA |
NA |
NA |
TTD |
| CYP2C9 |
4-(2,4-dichlorophenyl)-1-(1-(2-(pyrrolidin-1-yl)ethyl)-1H-indazol-5-yl)pyridin-2(1H)-one |
NA |
10000000 |
NA |
NA |
NA |
NA |
TTD |
| CYP2C9 |
2,3-Butanediol |
NA |
NA |
NA |
NA |
101035 |
NA |
PubChem |
| CYP2C9 |
9,12-Octadecadienoic acid (9Z,12Z)-, dimer, diisoeicosyl ester |
NA |
NA |
NA |
NA |
106301 |
NA |
PubChem |
| CYP2C9 |
2-(4-{[(2S)-8-Methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinolin-2-yl]methyl}piperazin-1-yl)-quinoline-6-carbonitrile |
NA |
358000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| CYP2C9 |
3-(4-Methyl-imidazol-1-yl)-pyridine |
NA |
300000 |
NA |
NA |
NA |
NA |
TTD |
| CYP2C9 |
(5-Pyridin-3-ylthiophen-2-yl)methanamine;(5-pyridin-3-ylthiophen-2-yl)methanimine |
NA |
208000 |
NA |
NA |
NA |
NA |
TTD |
| CYP2C9 |
Nicotinoyl guanidine, 29 |
NA |
122000 |
NA |
NA |
NA |
NA |
TTD |
| CYP2C9 |
Nicotinoyl guanidine, 33 |
NA |
122000 |
NA |
NA |
NA |
NA |
TTD |
| CYP2C9 |
Posaconazole |
NA |
109000 |
NA |
NA |
NA |
NA |
BindingDB|PubChem |
| CYP2C9 |
5-[(2r,4s)-2-(Phenylmethyl)piperidin-4-Yl]-1,2-Oxazol-3-One |
NA |
20000000 |
NA |
NA |
NA |
NA |
TTD |
| CYP2C9 |
5-[(2S,4S)-2-(2-phenylethyl)piperidin-4-yl]-1,2-oxazol-3-one |
NA |
20000000 |
NA |
NA |
NA |
NA |
TTD |
| CYP2C9 |
5-[(2R,4S)-2-(2,2-Dimethylpropyl)-4-piperidinyl]-3(2H)-isoxazolone |
NA |
20000000 |
NA |
NA |
NA |
NA |
TTD |
| CYP2C9 |
1-[5-(4-Cyanophenyl)-2-bicyclo[3.1.0]hexanyl]-3-[4-fluoro-3-(trifluoromethyl)phenyl]-1-[3-(4-methylpiperazin-1-yl)propyl]urea |
NA |
10000000 |
NA |
NA |
NA |
NA |
TTD |
| CYP2C9 |
Sulfaphenazole |
NA |
318000 |
NA |
NA |
NA |
NA |
BindingDB|PubChem |
| CYP2C9 |
Thiabendazole |
245000 |
NA |
NA |
NA |
NA |
NA |
BindingDB|PubChem|TTD |
| CYP2C9 |
(NE)-N-[(5-pyridin-3-ylfuran-2-yl)methylidene]hydroxylamine;(NZ)-N-[(5-pyridin-3-ylfuran-2-yl)methylidene]hydroxylamine |
NA |
141000 |
NA |
NA |
NA |
NA |
TTD |
| CYP2C9 |
Lysergide |
NA |
NA |
NA |
NA |
104300 |
NA |
PubChem |
| CYP2C9 |
3,3'-Bipyridine |
NA |
300000 |
NA |
NA |
NA |
NA |
TTD |